RWE AG
PSE:RWE
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
R
|
RWE AG
PSE:RWE
|
DE |
|
Sarepta Therapeutics Inc
NASDAQ:SRPT
|
US |
|
RTL Group SA
F:RRTL
|
LU |
|
I
|
iQ International AG
XBER:IQL
|
CH |
|
K
|
KDDI Corp
DUS:DIP
|
JP |
|
P
|
Pfizer Inc
DUS:PFE
|
US |
Wall St Price Targets
RWE Price Targets Summary
RWE AG
According to Wall Street analysts, the average 1-year price target for
RWE is 1 529.23 CZK with a low forecast of 896.15 CZK and a high forecast of 1 740.43 CZK.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is RWE's stock price target?
Price Target
1 529.23
CZK
According to Wall Street analysts, the average 1-year price target for
RWE is 1 529.23 CZK with a low forecast of 896.15 CZK and a high forecast of 1 740.43 CZK.
What is the Revenue forecast for RWE AG?
Projected CAGR
10%
Over the last 14 years, the compound annual growth rate for Revenue has been -7%. The projected CAGR for the next 5 years is 10%.
What is the Operating Income forecast for RWE AG?
Projected CAGR
29%
Over the last 14 years, the compound annual growth rate for Operating Income has been -10%. The projected CAGR for the next 6 years is 29%.
What is the Net Income forecast for RWE AG?
Projected CAGR
1%
Over the last 14 years, the compound annual growth rate for Net Income has been 4%. The projected CAGR for the next 6 years is 1%.